Trial intelligence / Profile preview

Preemptive analgesia with pregabalin and celecoxib in total knee arthroplasty

ChiCTR2100041595Phase 4Recruiting

Sponsor
The Third Affiliated Hospital of Zunyi Medical University
Start
Jan 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of pregabalin and celecoxib in knee osteoarthritis (OA) and postoperative pain (4 arms), sponsored by The Third Affiliated Hospital of Zunyi Medical University. Primary endpoints: Postoperative pain (VAS score) and Cumulative opioid consumption. Started Jan 2021; status: recruiting.

02

Drugs

pregabalincelecoxib
03

Conditions

knee osteoarthritis (OA)postoperative pain

Beyond the preview

Go deeper on ChiCTR2100041595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100041595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call